Welcome to our dedicated page for Tempus AI SEC filings (Ticker: TEM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Tempus AI's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Tempus AI's regulatory disclosures and financial reporting.
TEM: Individual filed a Form 144 proposing a sale of $566,405.34 of Class A Common Stock. The filing lists a sale of 9,592 shares on 02/19/2026. The submission also itemizes previously issued Restricted Stock Units granted on multiple dates with discrete share counts.
Tempus AI, Inc. executive Fukushima Ryan, CEO, Data, reported two bona fide gifts of Class A Common Stock. On May 14, 2026, he transferred 62,239 shares held indirectly through his spouse and 162,239 shares held directly, both at a price of $0.00 per share. Following these gifts, he holds 211,047 shares indirectly via his spouse and 617,108 shares directly. The footnote states these were bona fide gifts for no consideration and that both he and his spouse are subject to a lock-up agreement expiring on June 21, 2026, with this gift treated as a permissible exemption under that lock-up.
Tempus AI, Inc. completed a private offering of $460.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2032, using an indenture with U.S. Bank Trust Company as trustee. The notes are unsecured, carry no regular interest and mature on May 15, 2032, with special interest only in defined circumstances.
Net proceeds were approximately $441.9 million, of which Tempus repaid $307.7 million of outstanding loans under its senior secured credit facilities and spent about $31.2 million on capped call transactions, with the balance for general corporate purposes. The initial conversion rate is 14.4388 shares per $1,000 principal (conversion price about $69.26, a 40% premium), and a maximum of 9,298,532 shares may be issuable based on a higher maximum conversion rate. Capped call transactions, struck at an initial cap price of $98.94, are intended to reduce dilution or offset cash paid above principal on conversion.
Tempus AI, Inc. Schedule 13G/A amendment shows Baillie Gifford & Co. beneficially owned 8,649,356 shares of Tempus AI common stock, equal to 4.98% of the class as of 03/31/2026. The filing lists 8,615,766 shares as sole voting power and 8,649,356 as sole dispositive power. The filing is signed by Grant Meikle on 05/07/2026.
Schoenherr Thomas Edward reported acquisition or exercise transactions in this Form 4 filing.
Tempus AI, Inc. executive Thomas Edward Schoenherr, CEO of Diagnostics, received an equity award reported as 13,642 shares of Class A Common Stock. This represents two restricted stock unit grants: 3,642 RSUs are fully vested, and 10,000 RSUs will vest in eight equal quarterly installments starting on November 15, 2026. Following this grant, Schoenherr directly holds 108,609 shares of Class A Common Stock. The transaction reflects a compensation-related share award rather than an open-market purchase or sale.
Rogers James William reported acquisition or exercise transactions in this Form 4 filing.
Tempus AI, Inc. reported that its Chief Financial Officer, James William Rogers, received a grant of 10,000 shares of Class A Common Stock in the form of restricted stock units. The award was granted at no cash cost to him and is part of his compensation. The RSUs vest in eight equal quarterly installments beginning on November 15, 2026. Following this grant, he holds 137,248 shares of Class A Common Stock directly.
Polovin Andrew reported acquisition or exercise transactions in this Form 4 filing.
Tempus AI, Inc. reported that EVP and Chief Legal Officer Andrew Polovin received a grant of 10,000 shares of Class A Common Stock in the form of restricted stock units. The RSUs vest in eight equal quarterly installments starting on November 15, 2026. After this award, he directly holds 136,918 shares.
Bartolucci Ryan M reported acquisition or exercise transactions in this Form 4 filing.
Tempus AI, Inc. reported that its Chief Accounting Officer, Ryan M. Bartolucci, received an award of 24,000 shares of Class A Common Stock in the form of restricted stock units. Following this grant, he directly holds 78,157 shares. The RSUs vest in twelve equal quarterly installments beginning on November 15, 2026.
Fukushima Ryan reported acquisition or exercise transactions in this Form 4 filing.
Tempus AI, Inc. executive Ryan Fukushima reported a compensation-related grant of 10,000 shares of Class A Common Stock in the form of restricted stock units. The award was granted at a price of $0 per share and will vest in eight equal quarterly installments starting November 15, 2026.
Following this grant, Fukushima holds 779,347 shares of Class A Common Stock directly, and 148,808 shares are reported as indirectly owned through his spouse. The filing does not show any open-market buying or selling, only the new equity award and an updated indirect holding entry.
Tempus AI, Inc. reported total net revenue of 348,116 (in thousands) for the three months ended March 31, 2026, up from 255,737 (in thousands) a year earlier, driven by growth in both Diagnostics and Data and applications.
Diagnostics revenue reached 261,098 (in thousands), while Data and applications contributed 87,018 (in thousands). Net loss widened to 125,919 (in thousands), compared with 68,037 (in thousands) in the prior-year period, and basic net loss per share was 0.70.
Operating activities used cash of 73,277 (in thousands), but the company ended the quarter with cash, cash equivalents and restricted cash totaling 525,864 (in thousands) and total assets of 2,135,091 (in thousands). Management states that existing cash, cash equivalents and marketable equity securities as of March 31, 2026 will be sufficient to fund the current operating plan for at least one year.